Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;48(7):954-957.
doi: 10.1007/s00134-022-06750-w. Epub 2022 Jun 7.

Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists

Iwan A Meynaar  1 , Simone van Rijn  2 , Thomas H Ottens  3 , Nathalie D van Burgel  4 , Cees van Nieuwkoop  5
Affiliations

Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists

Iwan A Meynaar et al. Intensive Care Med. 2022 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. Centers or Disease Control And Prevention. Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection). 2022.
    1. Patel PR, Weiner-Lastinger LM, Dudeck MA, Fike LV, Kuhar DT, Edwards JR, et al. Impact of COVID-19 Pandemic on Central Line-Associated Bloodstream Infections during the Early Months of 2020, National Healthcare Safety Network. Infect Control Hosp Epidemiol. 2020 doi: 10.1017/ice.2021.108. - DOI - PMC - PubMed
    1. Baker MA, Sands KE, Huang SSAIE. The impact of COVID-19 on healthcare-associated infections. Clin Infect Dis. 2021 doi: 10.1093/cid/ciab688. - DOI - PMC - PubMed
    1. van Paassen J, Vos JS, Hoekstra EM, Neumann KMI, Boot PC, Arbous SM. Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. Crit Care. 2020;24:696. doi: 10.1186/s13054-020-03400-9. - DOI - PMC - PubMed
    1. Snow TAC, Saleem N, Ambler G, Nastouli E, Singer M, Arulkumaran N. Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials. Intensive Care Med. 2021;47:641–652. doi: 10.1007/s00134-021-06416-z. - DOI - PMC - PubMed

MeSH terms